Leveljump Healthcare Corp. (FRA:75J)
Germany
· Delayed Price · Currency is EUR 0.0300
0.00 (0.00%)
At close: Dec 5, 2025
Leveljump Healthcare Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Revenue | 18.91 | 17.73 | 12.58 | 9.23 | 6.72 | 5.46 | Upgrade
|
| Revenue Growth (YoY) | 12.42% | 40.91% | 36.35% | 37.33% | 23.16% | 1.54% | Upgrade
|
| Cost of Revenue | 13.94 | 13.18 | 9.71 | 7.37 | 5.37 | 6.54 | Upgrade
|
| Gross Profit | 4.97 | 4.55 | 2.87 | 1.86 | 1.35 | -1.08 | Upgrade
|
| Selling, General & Admin | 1.07 | 0.95 | 1.02 | 1.96 | 2.77 | 0.97 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.49 | 0.49 | 0.26 | 0.11 | - | - | Upgrade
|
| Other Operating Expenses | 1.9 | 2.01 | 2.08 | - | - | - | Upgrade
|
| Operating Expenses | 4.41 | 4.61 | 3.69 | 2.54 | 3.55 | 1.07 | Upgrade
|
| Operating Income | 0.56 | -0.06 | -0.82 | -0.68 | -2.2 | -2.15 | Upgrade
|
| Interest Expense | -1.07 | -1.07 | -0.4 | -0.14 | -0.04 | -0.08 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.01 | 0.01 | 0 | -0 | 0 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.13 | -0.04 | -2.33 | -0.02 | 0.04 | -0.58 | Upgrade
|
| EBT Excluding Unusual Items | -0.37 | -1.17 | -3.55 | -0.85 | -2.2 | -2.81 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.1 | 0.1 | 1.09 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.04 | 0.04 | 0.02 | -0 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | 1.04 | -0.03 | -8.75 | Upgrade
|
| Pretax Income | -0.23 | -1.03 | -2.44 | 0.19 | -2.23 | -11.56 | Upgrade
|
| Income Tax Expense | -2.19 | -2.19 | -0.24 | - | - | - | Upgrade
|
| Net Income | 1.96 | 1.16 | -2.21 | 0.19 | -2.23 | -11.56 | Upgrade
|
| Net Income to Common | 1.96 | 1.16 | -2.21 | 0.19 | -2.23 | -11.56 | Upgrade
|
| Shares Outstanding (Basic) | 96 | 96 | 92 | 79 | 48 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 110 | 110 | 92 | 79 | 48 | 3 | Upgrade
|
| Shares Change (YoY) | 13.97% | 19.71% | 15.86% | 66.18% | 1697.13% | - | Upgrade
|
| EPS (Basic) | 0.02 | 0.01 | -0.02 | 0.00 | -0.05 | -4.36 | Upgrade
|
| EPS (Diluted) | 0.02 | 0.01 | -0.02 | 0.00 | -0.05 | -4.36 | Upgrade
|
| Free Cash Flow | 1.27 | 0.72 | -1.05 | -0.03 | -1.79 | -2.99 | Upgrade
|
| Free Cash Flow Per Share | 0.01 | 0.01 | -0.01 | - | -0.04 | -1.13 | Upgrade
|
| Gross Margin | 26.27% | 25.64% | 22.81% | 20.14% | 20.12% | -19.78% | Upgrade
|
| Operating Margin | 2.96% | -0.37% | -6.54% | -7.41% | -32.70% | -39.40% | Upgrade
|
| Profit Margin | 10.34% | 6.55% | -17.55% | 2.00% | -33.17% | -211.94% | Upgrade
|
| Free Cash Flow Margin | 6.71% | 4.05% | -8.32% | -0.32% | -26.66% | -54.71% | Upgrade
|
| EBITDA | 0.95 | 0.86 | -0.57 | -0.57 | -2.2 | -2.14 | Upgrade
|
| EBITDA Margin | 5.01% | 4.85% | -4.50% | -6.19% | -32.68% | -39.15% | Upgrade
|
| D&A For EBITDA | 0.39 | 0.93 | 0.26 | 0.11 | 0 | 0.01 | Upgrade
|
| EBIT | 0.56 | -0.06 | -0.82 | -0.68 | -2.2 | -2.15 | Upgrade
|
| EBIT Margin | 2.96% | -0.37% | -6.54% | -7.41% | -32.70% | -39.40% | Upgrade
|
| Revenue as Reported | - | - | - | 9.23 | 6.72 | 5.46 | Upgrade
|
| Advertising Expenses | - | 0.04 | 0.03 | - | 0.68 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.